Riskpilot← Back to searchSign inGet full accessCHRYSOPIDAE AS
ASActiveOrg 817753892Fredensborgveien 22G, 0177 OsloWholesale of beverages · NACE 4634Est. 20160 employees
Revenue 2024
NOK 11,5M
-12% vs 2023
EBITDA margin
5.1%
-41% vs 2023
Equity ratio
0.7%
Financial strength
Net profit 2024
NOK 406K
-42% vs 2023
| Revenue | NOK 11,5M | -12% |
| EBITDA | NOK 584K | -41% |
| Net profit | NOK 406K | -42% |
| Total assets | NOK 11,4M | +249% |
| Equity | NOK 77K | -3% |
| Employees | 0 | — |
Legal name
CHRYSOPIDAE AS
Org number
817753892
Legal form
Aksjeselskap
NACE code
4634 · Wholesale of beverages
Founded
20. september 2016
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Engroshandel med vin og brennevin samt alt som naturlig står i forbindelse med dette.
Address
Fredensborgveien 22G, 0177 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 164 | 14 572 | 10 413 | 13 047 | 11 454 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 600 | 1 672 | −129 | 992 | 584 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 600 | 1 672 | −129 | 992 | 584 |
| Net financials | −15 | −110 | 141 | −145 | −63 |
| Profit before tax | 1 585 | 1 562 | 12 | 848 | 521 |
| Tax | 348 | 344 | −0 | 145 | 115 |
| Net profit | 1 236 | 1 218 | 12 | 702 | 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 636 | 3 733 | 3 641 | 3 276 | 11 443 |
| Equity | 66 | 65 | 77 | 79 | 77 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 570 | 3 669 | 3 565 | 3 197 | 11 366 |
| Total debt | 7 570 | 3 669 | 3 565 | 3 197 | 11 366 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20202024
Equity ratio
0.7%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
526.3%
This company
18.4%
Market median
+2760% vs market
20202024
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20202024
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20202024
Debt / equity
147.49×
This company
0.62×
Market median
-23689% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Chief Executive Officer | Chief Executive Officer | 2016 |
| Former (1) | ||
TN Chief Executive Officer | Chief Executive Officer | 2016 – 2021 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bubo Holding As
CHRYSOPIDAE AS Board members of CHRYSOPIDAE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Nordrik Meling-Lorntzen | Chief Executive Officer | 0 companies |
| Terje Nordrik Meling | Chief Executive Officer | 0 companies |